HOME >> MEDICINE >> NEWS
Adding medication improves recovery for elderly with depression, says Pitt School of Medicine study

PITTSBURGH, June 1 Adding a medication to a standard treatment regimen for major depressive disorder in the elderly improves chances of recovery in those who do not adequately respond to the first-course therapy or who relapse from it, finds a University of Pittsburgh School of Medicine study published in the June issue of the American Journal of Psychiatry, the official journal of the American Psychiatric Association. Up to 84 percent of the elderly who experience depression either fail to respond to first-course treatment or relapse during the first six to 12 weeks of treatment.

The study found that adding a second drug to the treatment of depressed participants over the age of 70 who either did not respond to initial treatment with the antidepressant paroxetine and interpersonal psychotherapy, or to those who responded to the initial treatment but quickly relapsed, caused the likelihood of recovery to rise from 40 percent to 60 percent. Recovery was slower in those who did not respond to the original treatment.

Depression should not be considered a normal part of aging. The scientific evidence is growing that there are a number of effective treatment options available for people of all ages, said Mary Amanda Dew, Ph.D., professor of psychiatry, psychology and epidemiology at the University of Pittsburgh and lead author of the study.

The University of Pittsburgh researchers followed 105 adults aged 70 or older who had major depressive disorder and who did not respond to standardized treatment of paroxetine and interpersonal psychotherapy or who did respond but experienced an early recurrence of depressive symptoms. Participants were given one of three augmenting agents: sustained-release bupropion, nortriptyline or lithium. Researchers selected the additional agent that each participant received based on individual medical status and history. Thirty-six participants either declined new medicine or did not receive augmentatio
'"/>

Contact: Jocelyn Uhl Duffy
UhlJH@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
1-Jun-2007


Page: 1 2

Related medicine news :

1. Adding radioimmunotherapy to chemo may help patients with lymphoma
2. Adding radiation decreases breast cancer recurrence
3. Heart failure medication does not improve survival, compared to more widely used medication
4. Commonly used pain medications do not prevent Alzheimers disease
5. Standard long-acting insulin as good as newer medications
6. MS patients not receiving medications to slow disease progression, research shows
7. Study sheds light on medication treatment options for bipolar disorder
8. Landmark schizophrenia treatment study reveals that medication alone is not always effective
9. Cost control measures limit patient and physician choice in psychotropic medications
10. Residents in disaster areas face medication adherence dilemmas
11. Improved adherence to certain medications associated with longer survival following heart attack

Post Your Comments:
(Date:6/18/2013)... DC (PRWEB) June 18, 2013 The ... Department of State and the U.S. President’s Emergency Plan ... anniversary and celebrate significant new milestones in the global ... State John Kerry announced that as of June 2013, ... to PEPFAR support. Since PEPFAR’s inception in 2003, ...
(Date:6/18/2013)... 2013 Two months ago, Suyima Torres, 28, ... for a second session of a silicone treatment for gluteus ... treatment was allegedly performed by a mystery Venezuelan doctor in ... According to Dr. Bernabe Vazquez of Bayshore Cosmetic Surgery ... from doctor’s who are not board certified is more common ...
(Date:6/18/2013)... A new $119 million industry is ... industry is redefining the way consumers get their seafood. ... personal culinary chefs on the Emerald Coast panhandle of ... seafood and the promising industry of aquaculture. , The ... consumers strive to fully partake in the effort, especially ...
(Date:6/18/2013)... York (PRWEB) June 18, 2013 As ... state and federal court, a new report has revealed that ... 70,000 U.S. Food & Drug Administration (FDA) adverse event reports ... NewsChannel5 in Cleveland, Ohio, over 4.700 Mirena users have reported ... more than 1,300 have reportedly experienced uterine perforations due to ...
(Date:6/18/2013)... New York, NY (PRWEB) June 18, 2013 ... Sinai Medical Center to its “Best Doctors” list, up ... in New York City. The new issue also lists 52 ... network, which continues on a strategic growth trajectory. The “Best ... physicians, appears in the June 24 print issue and is ...
Breaking Medicine News(10 mins):Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 2Health News:Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection 3Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3
(Date:6/18/2013)... BURLINGTON, Mass. , June 18, 2013 /PRNewswire/ ... and advisory firms for pharmaceutical and healthcare issues, ... includes coverage of the Middle East ... Market Access Tracker analyzes the challenges and opportunities ... in four international regions comprising 24 countries. The ...
(Date:6/18/2013)... MINNEAPOLIS , June 18, 2013 ... while being highly portable and lightweight. Simultaneously, circuitry ... and the processing speed to which it performs ... both medical electronics and military equipment, such as ... lightweight. Omnetics, micro-circular and nano-circular connectors include custom ...
(Date:6/18/2013)... SYDNEY, Australia And EMERYVILLE, ... Adamas Pharmaceuticals, Inc. presented final results today from ... HCl extended release) capsules demonstrating a statistically significant ... change from baseline at week 8 versus placebo ... is Adamas, investigational extended-release formulation of amantadine intended ...
Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
Cached News: